Q BioMed Inc has initiated production of Strontium-89 Chloride, a radiopharmaceutical indicated for the analgesic treatment of metastatic breast and prostate cancer bone pain.
T cells are widely known as being crucial in the fight against cancer within the body but little was known, previously, about what happened after their role was after infiltrating a tumour.